RNXT
RenovoRx Roars into Q2 with Record Revenue, Accelerating Commercial Momentum
RenovoRx has officially taken the stage as a force to be reckoned with in the medical industry, having just reported record revenue for its second quarter of 2026. According to the company's latest conference call transcript, RenovoRx generated a staggering $909,000 in revenue, a 61% sequential increase